Treatment of Intertrochanteric Fracture With New Type of Intramedullary Nail

September 17, 2022 updated by: Peifu Tang
The purpose of this study is to determine whether this new intramedullary fixation is effective in the treatment of intertrochanteric fracture.

Study Overview

Detailed Description

With the progress of aging society, elderly patients with intertrochanteric fractures were occurred more and more. The best recommend treatment is surgical treatment of intramedullary fixation. However, existing methods of intramedullary fixation could not be restored the integrated interior support, and it will occur early hip varus. Meanwhile, the varus deformity will no longer develop if the two ends contact with wach other. This new intramedullary fixation device can overcome the existing shortage of intramedullary fixation devices and supporting the inside of the problem. It can prompting the fracture site to obtain a stronger initial stability, improve fracture healing rate, reduce the incidence of varus and allow patients with early weight-bearing walking.

This new type of intramedullary fixation of intertrochanteric fractures of devices, including a proximal femoral anatomy and adapt to proximal femoral nail, proximal femoral nail through the femoral head and distal femur compression screw locking screw, its main features are:

  1. The proximal femoral nail was made from titanium, its proximal part is narrow inside and wide outside structure. It looks like a trapezoidal in cross-section. This device was matched with the anatomy of proximal femur and its mechanical reliability.
  2. The tip of compression screw was designed thread. It can come through the intramedullary nail, produce slide and sustained pressure.
  3. The femoral support screw was made in cylindrical, had a blunt rounded tip. The tip of the femoral support screw was tabling with the groove of compression screw. This design can support interior mechanical stability. At the same time, the support screw from the femoral head and neck compression screw can slide fine-tuning, so it has a direct offset against varus and femoral neck rotating shift to prevent secondary loss of fracture reduction. The screw in the femoral head also can prevent cutting occurs.
  4. This device can be used in minimally invasive approach of percutaneous and implanted in body. Reduce reduction time, fracture interference and help the natural healing of fractures.

Study Type

Interventional

Enrollment (Anticipated)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Beijing
      • Beijing, Beijing, China, 100853
        • Recruiting
        • Orthopedics department; The General Hospital of the People's Liberation Army
        • Contact:
        • Principal Investigator:
          • Zhang li Hai, Dr.
        • Sub-Investigator:
          • Shen Jing, Dr.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Adult men or women aged 18 years and older (with no upper age limit).
  • Fracture of the intertrochanteric fracture confirmed with either anteroposterior and lateral hip radiographs, computed tomography, or magnetic resonance imaging (MRI).
  • Operative treatment of fractures within 14 days of presenting to the emergency room.
  • Patient was ambulatory prior to fracture, though they may have used an aid such as a cane or a walker.
  • Anticipated medical optimalization for operative fixation of the hip.
  • Provision of informed consent by patient or legal guardian.
  • No other major trauma.

Exclusion Criteria:

  • Patients not suitable for internal fixation (i.e., severe osteoarthritis, rheumatoid arthritis, or pathologic fracture).
  • Associated major injuries of the lower extremity (i.e., ipsilateral or contralateral fractures of the foot, ankle, tibia, fibula, knee, or femur; dislocations of the ankle, knee, or hip; or femoral head defects or fracture).
  • Retained hardware around the affected hip.
  • Infection around the hip (i.e., soft tissue or bone).
  • Patients with disorders of bone metabolism except osteoporosis (i.e., Paget's disease, renal osteodystrophy, osteomalacia).
  • Moderate or severe cognitively impaired patients (i.e., Six Item Screener with 3 or more errors).
  • Patients with Parkinson's disease (or dementia) severe enough to increase the likelihood of falling or severe enough to compromise rehabilitation.
  • Likely problems, in the judgment of the investigators, with maintaining follow-up. We will, for example, exclude patients with no fixed address, those who report a plan to move out of town in the next year, or intellectually challenged patients without adequate family support

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: DOUBLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Unstable intertrochanteric fracture fixed with novel nail
AO/OTA A2 fracture fixed with novel nail
This is a new fixation treat for intertrochanteric fracture.
Other Names:
  • WEIGAO ORTHOPAEDIC DEVICE CO.LTD.
  • ZL201020121021.6
EXPERIMENTAL: unstable intertrochanteric fracture fixed with PFNA
AO/OTA A2 fracture fixed with PFNA
It was used very common in treat with intertrochanteric fracture.
Other Names:
  • AO Foundation
  • PFNA(proximal femoral nail antirotation)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Postoperative quality of life score
Time Frame: preoperative, six months and one year postoperative
SF-36 PCS
preoperative, six months and one year postoperative

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
rate of fracture healing at three months
Time Frame: three months postoperative
fracture healing condition was checked by radiological examination.
three months postoperative
rate of femoral medialization
Time Frame: one year postoperative
femoral medialization
one year postoperative
collodiaphyseal angle
Time Frame: one year postoperative
collodiaphyseal angle
one year postoperative
weight bearing
Time Frame: perioperation
time of weight bearing
perioperation
rate of patient satisfaction with treatment
Time Frame: one year postoperative
1-year VAS satisfaction
one year postoperative
Hip function score
Time Frame: preoperative, six months and one year postoperative
OHS
preoperative, six months and one year postoperative
time of surgical during
Time Frame: Perioperative
The time from the beginning to the end of the surgery
Perioperative
fluoroscopy time
Time Frame: intraoperative
Duration of fluoroscopy
intraoperative
rate of complications related to implant
Time Frame: one year
cut out, nonunion, implant breakage/failure, infection
one year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Study Chair: Tang Peifu, Chinese PLA General Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2011

Primary Completion (ACTUAL)

September 1, 2022

Study Completion (ANTICIPATED)

August 1, 2024

Study Registration Dates

First Submitted

September 1, 2011

First Submitted That Met QC Criteria

September 19, 2011

First Posted (ESTIMATE)

September 20, 2011

Study Record Updates

Last Update Posted (ACTUAL)

September 21, 2022

Last Update Submitted That Met QC Criteria

September 17, 2022

Last Verified

September 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • PLAGH OD 12

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Intertrochanteric Fracture

Clinical Trials on new type of intramedullary nail

Subscribe